[144] General Motors Company SEC Filing

Rhea-AI Filing Summary

Form 144 filed for General Motors Company (GM) discloses a proposed sale of 14,667 common shares to be executed through Morgan Stanley Smith Barney LLC with an aggregate market value of $862,419.60, representing part of 952,077,801 shares outstanding. The shares were acquired and are being sold on 08/27/2025 following the exercise of stock options, with payment in cash. The filing also reports prior 10b5-1 plan sales by the same person, Christopher T. Hatto, of 36,804 shares on 08/13/2025 for $2,027,969.84. The filer certifies no known material nonpublic information and references Rule 10b5-1 procedures where applicable.

Positive

• Transaction transparency: Filing specifies broker, share counts, values, and dates
• Acquisition method disclosed: Shares were acquired via exercise of stock options and payment was in cash
• Prior 10b5-1 sales disclosed: Demonstrates use of structured trading plan for earlier transactions

Negative

• Insider selling activity: 14,667 shares proposed for sale plus 36,804 shares sold on 08/13/2025 for $2,027,969.84
• Concentration note: While stated, the filing does not provide the seller's post-sale holdings, limiting context about ongoing ownership

Insights

Securities Analyst

TL;DR: Insiders are exercising options and selling a modest block of GM shares; transaction sizes are small relative to outstanding stock.

The filing documents a straightforward insider liquidity transaction: 14,667 shares acquired by exercise and submitted for sale the same day through a major broker, with cash payment. The filing also discloses a prior Rule 10b5-1 sale of 36,804 shares generating about $2.03 million. These are explicit, routine disclosures showing insider monetization rather than corporate operational changes. Given the 952 million shares outstanding, the disclosed sales do not, on their face, constitute material dilution or a direct change to GM's capital structure.

Corporate Governance Expert

TL;DR: Disclosure follows required procedures; use of broker and mention of 10b5-1 sales align with standard compliance.

The report includes the required representation that the seller does not possess undisclosed material information and notes prior 10b5-1 plan activity. The use of a registered broker and explicit dates for acquisition and sale support transparency. There is no indication of irregularity in the filing itself; it documents compliance with Rule 144 sale notification requirements and provides the necessary transaction-level detail for investor oversight.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14667	862419.60	952077801	08/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/27/2025	Exercise of Stock Options	Issuer			14667	08/27/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHRISTOPHER T HATTO 300 RENAISSANCE CENTER DETROIT MI 48265	Common	08/13/2025	36804	2027969.84

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the GM Form 144 report propose to sell?

The filing proposes the sale of 14,667 common shares of GM with an aggregate market value of $862,419.60.

When were the shares acquired and when is the sale planned?

The shares were acquired by exercise of stock options on 08/27/2025 and the approximate date of sale is 08/27/2025.

Through which broker will the GM shares be sold?

The sale is to be executed through Morgan Stanley Smith Barney LLC.

Has the filer sold other GM shares recently?

Yes. The filing discloses a 10b5-1 sale of 36,804 shares on 08/13/2025 generating $2,027,969.84 in gross proceeds.

Does the filing state whether the seller has material nonpublic information?

Yes. By signing, the person represents they do not know any material adverse information

How large are these transactions relative to GM's outstanding shares?

The filing lists 952,077,801 shares outstanding; the proposed sale of 14,667 shares is a very small fraction of that total.